Jack Samways

ORCID: 0000-0001-9090-9610
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Heart Failure Treatment and Management
  • Medication Adherence and Compliance
  • Cardiac pacing and defibrillation studies
  • Cardiac Arrhythmias and Treatments
  • Mobile Health and mHealth Applications
  • Atrial Fibrillation Management and Outcomes
  • Cardiovascular Function and Risk Factors
  • Meta-analysis and systematic reviews
  • Cardiac Health and Mental Health
  • Health Systems, Economic Evaluations, Quality of Life
  • Healthcare cost, quality, practices
  • Coronary Interventions and Diagnostics
  • Liver Disease and Transplantation
  • Digital Mental Health Interventions
  • Vascular Anomalies and Treatments
  • Emergency and Acute Care Studies
  • Chronic Disease Management Strategies
  • COVID-19 Clinical Research Studies
  • Recreation, Leisure, Wilderness Management
  • Hospital Admissions and Outcomes
  • Maternal and fetal healthcare
  • Congenital Heart Disease Studies
  • Healthcare Policy and Management
  • Artificial Intelligence in Healthcare
  • Cystic Fibrosis Research Advances

Imperial College London
2022-2024

Imperial College Healthcare NHS Trust
2020-2024

National Health Service
2023

Hammersmith Hospital
2023

London North West Healthcare NHS Trust
2022

King's College London
2022

Barts Health NHS Trust
2018

Whipps Cross University Hospital
2018

University of Manchester
2014-2016

University of Wales Trinity Saint David
2015

Background Community-based management by heart failure specialist nurses (HFSNs) is key to improving self-care in with reduced ejection fraction. Remote monitoring (RM) can aid nurse-led management, but the literature, user feedback evaluation skewed favor of patient rather than nursing experience. Furthermore, ways which different groups use same RM platform at time are rarely directly compared literature. We present a balanced semantic analysis from and nurse perspectives Luscii,...

10.2196/44630 article EN cc-by JMIR Nursing 2023-06-06

Background Despite effective therapies, the economic burden of heart failure with reduced ejection fraction (HFrEF) is driven by frequent hospitalizations. Treatment optimization and admission avoidance rely on symptom reviews monitoring vital signs. Remote (RM) aims to prevent admissions facilitating early intervention, but impact noninvasive, smartphone-based RM signs secondary health care use costs in months after a new diagnosis HFrEF unknown. Objective The purpose this study conduct...

10.2196/45611 article EN cc-by JMIR Cardio 2023-06-23

Abstract Aims Specialist cardiology care is associated with a prognostic benefit in patients heart failure (HF) reduced ejection fraction (HFrEF) admitted decompensated HF. However, up to one third of HF and normal (HFnEF) do not receive specialist input. Whether this has implications unknown. Methods results Data on hospitalized HFnEF from two tertiary centres were analysed. The primary outcome measure was all‐cause mortality during follow‐up. secondary in‐hospital mortality. A total 1413...

10.1002/ehf2.14440 article EN cc-by ESC Heart Failure 2023-06-25

Background: The prognostic impact of ventricular tachycardia (VT) catheter ablation is an important outstanding research question. We undertook a reconstructed individual patient data meta-analysis randomised controlled trials comparing to medical therapy in patients developing VT after MI. Methods: systematically identified all with and prior prespecified primary endpoint was assessment all-cause mortality. Prespecified secondary endpoints included trial-level mortality, recurrence or...

10.15420/aer.2023.07 article EN cc-by-nc Arrhythmia & Electrophysiology Review 2023-11-22

Abstract Background Patients with heart failure (HF) and left bundle branch block (LBBB) are selected for biventricular pacing (BVP) cardiac resynchronisation therapy (CRT) based on their 12-lead ECG QRS complex duration (QRSd). This is due to the long-held belief that BVP delivers its beneficial effects almost exclusively by reducing ventricular dyssynchrony. Recent work (1) suggests atrioventricular delay (AVD) shortening another key mechanism of benefit and, therefore, timing may be an...

10.1093/europace/euae102.450 article EN cc-by-nc EP Europace 2024-05-01

The Disability Discrimination Act (1995, amended 2005), Equality (Citation2010), EU Action Plan (2003 –2010), and Strategy (2010–2020) were designed to make equal opportunities a “reality.” As 16% of the population, is statutorily disabled there are considerable implications for beach management. Research examples users include swimmers, anglers, etc. - but rarely people with learning disabilities (LD). This paper considered LD their appreciation three different coastal classifications in...

10.1080/08920753.2015.1086948 article EN Coastal Management 2015-11-02

Cancer is one of the most common causes death worldwide. In response to this, there has been a vast development in pharmacological anti-cancer therapies. Unfortunately, many these therapies induce cardiac dysfunction and ultimately life shortening conditions such as heart failure, myocardial infarction arrhythmias. As result, their dose thus efficacy limited. This highlights need for more cardio-safe drugs. One potential class drug, which shown promise both an adjuvant mono-therapy,...

10.1136/heartjnl-2014-306916.25 article EN Heart 2014-11-21

<sec> <title>BACKGROUND</title> Despite effective therapies, the economic burden of heart failure with reduced ejection fraction (HFrEF) is driven by frequent hospitalizations. Treatment optimization and admission avoidance rely on symptom reviews monitoring vital signs. Remote (RM) aims to prevent admissions facilitating early intervention, but impact noninvasive, smartphone-based RM signs secondary health care use costs in months after a new diagnosis HFrEF unknown. </sec>...

10.2196/preprints.45611 preprint EN 2023-01-12

Abstract Background The prognostic impact of ventricular tachycardia (VT) catheter ablation is an important outstanding research question. Purpose We undertook a reconstructed individual patient data meta-analysis randomised controlled trials comparing to medical therapy in patients developing VT after myocardial infarction (MI). Methods systematically identified all with and prior MI. pre-specified primary endpoint was all-cause mortality assessed using obtained by digitisation published...

10.1093/eurheartj/ehad655.392 article EN European Heart Journal 2023-11-01

The Royal College of Surgeons recognises patient handover as the point at which patients are collectively their most vulnerable. Concerns were raised in a London teaching hospital surgical department regarding an unstructured system, poor access to relevant clinical information, and inadequate weekend staffing. A quality improvement programme was designed implemented respond these concerns improve safety. paper aims discuss issues.A structured questionnaire distributed staff results used...

10.1108/ijhcqa-08-2017-0148 article EN International Journal of Health Care Quality Assurance 2018-08-01

332 Coronary interventions: stents 27.4% (n=983) on ticagrelor and 3.7% (n=131) prasugrel.Patients receiving clopidogrel were older than other groups (64.3±11.2 vs. 62.1±10.9 58.8 ±11.1yrs),with higher prevalence of diabetes (33.2% 20.4% 25.9%),chronic kidney disease (7.3% 4.5% 3.0%) prior stroke (5.6% 3.0% but lower ACS presentation (44.6% 75.2%vs. 76.3%),p<0.01 for all.Prasugrel was less often prescribed to women (24.4% 23.9% 12.2%, p<0.01).Clopidogrel patients likely underwent radial PCI...

10.1093/eurheartj/ehy565.p1665 article EN European Heart Journal 2018-08-01

This is a systematic review protocol which outlines the basis and methodology for our intended at time of writing in study screening phase. Our aim to answer fundamental questions: To systematically identify RCTs published four leading medical journals between January 1st 2019 May 31st 2020. assess quality reporting such using CONSORT 2010 statement. any association with specialty or size type RCT rate adherence

10.1101/2020.07.06.20147074 preprint EN cc-by-nc medRxiv (Cold Spring Harbor Laboratory) 2020-07-07

Abstract Background Despite effective therapies, the economic burden of heart failure with reduced ejection fraction (HFrEF) is driven by frequent hospital attendances [1]. Treatment optimisation and admission avoidance relies on symptom review monitoring vital signs [2]. RM programmes aim to prevent admissions improve system efficiency enabling self-management [3]. Few studies evaluate impact in HFrEF, compared real-world matched controls [4]. We compare costs between patients using Luscii,...

10.1093/eurheartj/ehac544.2816 article EN European Heart Journal 2022-10-01

Abstract Background Heart failure with reduced ejection fraction (HFrEF) lowers patients' quality of life (QoL) [1]. Digital interventions such as ESC's “Heart Failure Matters” website aim to encourage patient-engagement &amp; self-management [2], which remain major challenges in HFrEF care. Although remote monitoring (RM) has been tested inconclusive impact on prognosis [3], its experience and engagement is unclear [4]. Furthermore, the perspective clinicians using RM technologies remains...

10.1093/eurheartj/ehac544.2808 article EN European Heart Journal 2022-10-01

Abstract Aims Specialist cardiology care is associated with a prognostic benefit in patients HF reduced ejection fraction (HFrEF) admitted decompensated heart failure (HF). However, up to one third of and normal (HFnEF) do not receive specialist input. Whether this has implications unknown. Methods Data on hospitalised HFnEF from two tertiary centres were analysed. The primary outcome measure was all-cause mortality during follow-up. secondary in-hospital mortality. Results A total 1,413...

10.1093/eurheartjsupp/suac121.437 article EN European Heart Journal Supplements 2022-12-14

Abstract Background Heart failure with reduced ejection fraction (HFrEF) lowers patients' quality of life (QoL) [1]. Digital interventions such as ESC's “Heart Failure Matters” website aim to encourage patient-engagement &amp; self-management [2], which remain major challenges in HFrEF care. Although remote monitoring (RM) has been tested inconclusive impact on prognosis [3], its experience and engagement is unclear [4]. Furthermore, the perspective clinicians using RM technologies remains...

10.1093/ehjdh/ztac076.2808 article EN cc-by-nc European Heart Journal - Digital Health 2022-12-22

Abstract Background Despite effective therapies, the economic burden of heart failure with reduced ejection fraction (HFrEF) is driven by frequent hospital attendances [1]. Treatment optimisation and admission avoidance relies on symptom review monitoring vital signs [2]. RM programmes aim to prevent admissions improve system efficiency enabling self-management [3]. Few studies evaluate impact in HFrEF, compared real-world matched controls [4]. We compare costs between patients using Luscii,...

10.1093/ehjdh/ztac076.2816 article EN cc-by-nc European Heart Journal - Digital Health 2022-12-22
Coming Soon ...